Skip to main content
. 2024 Jun 13;4:116. doi: 10.1038/s43856-024-00540-9

Table 1.

Information components (IC) calculated for CAR-T therapy (ND = 5,576) for the given adverse reactions

Reaction Name NA NAD IC IC025
Inflammatory/Effusive Events
C-Reactive Protein Increased 25,169 70 3.769 3.372
Capillary Leak Syndrome 1206 14 4.324 3.421
Myocarditis 28,484 2 −1.211 −3.804
Pericarditis 21,552 3 −0.363 −2.432
Pericardial Effusion 17,867 18 2.277 1.485
Cardiac Tamponade 2,897 0 −1.053 −11.377
Arrhythmic Events
Tachycardia 202,122 174 2.198 1.948
Atrial Fibrillation 79,948 45 1.569 1.073
Atrial Flutter 6773 8 2.274 1.062
Electrocardiogram QT Prolonged 27,465 9 0.763 −0.376
Ventricular Tachycardia/Ventricular Fibrillation 27,573 15 1.464 0.593
Cardiac Arrest 75,180 31 1.124 0.524
Hemodynamic Events
Hypotension 268,722 469 3.220 3.068
Sinus Tachycardia 14,075 18 2.571 1.779
Cardiomyopathy-Related Events
Stress Cardiomyopathy 2700 6 2.699 1.284
Ejection Fraction Decreased 10,708 11 2.209 1.184
Cardiac Failure 130,976 30 0.241 −0.369
Cardiogenic Shock 7138 5 1.592 0.029

IC025 > 0 is an indicator for significant adverse reaction signals, which are highlighted in bold; ND number of reports containing a given medication in VigiBase, NA number of reports containing a given adverse reaction in VigiBase, NAD number of reports containing a given drug-adverse reaction pair in VigiBase.